Chester S. Zygmont's most recent trade in Revelation Biosciences Inc was a trade of 390,614 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Oct. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Chester S. Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 390,614 | 395,645 | - | 1.3 | 499,986 | Common Stock |
| Revelation Biosciences Inc | Chester Zygmont S. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 15,048 | 15,076 | - | 3.9 | 58,236 | Common Stock |